Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun 8;7(2):35-40.
doi: 10.5365/WPSAR.2016.7.2.002. eCollection 2016 Apr-Jun.

Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011

Affiliations

Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011

Hoa Binh Nguyen et al. Western Pac Surveill Response J. .

Abstract

Introduction: Extensively drug-resistant tuberculosis (XDR-TB) represents an emerging public health problem worldwide. According to the World Health Organization, an estimated 9.7% of multidrug-resistant TB (MDR-TB) cases are defined as XDR-TB globally. The objective of this study was to determine the prevalence of drug resistance to second-line TB drugs among MDR-TB cases detected in the Fourth National Anti-Tuberculosis Drug Resistance Survey in Viet Nam.

Methods: Eighty clusters of TB cases were selected using a probability-proportion-to-size approach. To identify MDR-TB cases, drug susceptibility testing (DST) was performed for the four major first-line TB drugs. DST of second-line drugs (ofloxacin, amikacin, kanamycin, capreomycin) was performed on isolates from MDR-TB cases to identify pre-XDR and XDR cases.

Results: A total of 1629 smear-positive TB cases were eligible for culture and DST. Of those, DST results for first-line drugs were available for 1312 cases, and 91 (6.9%) had MDR-TB. Second-line DST results were available for 84 of these cases. Of those, 15 cases (17.9%) had ofloxacin resistance and 6.0% were resistant to kanamycin and capreomycin. Five MDR-TB cases (6.0%) met the criteria of XDR-TB.

Conclusion: This survey provides the first estimates of the proportion of XDR-TB among MDR-TB cases in Viet Nam and provides important information for local policies regarding second-line DST. Local policies and programmes that are geared towards TB prevention, early diagnosis and treatment with effective regimens are of high importance.

PubMed Disclaimer

References

    1. Global tuberculosis report 2015. Geneva: World Health Organization; 2015http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf?...accessed 16 May 2016
    1. Hoa NB, Sy DN, Nhung NV, Tiemersma EW, Borgdorff MW, Cobelens FG. National survey of tuberculosis prevalence in Viet Nam. Bull World Health Organ. 2010. April;88(4):273–80. 10.2471/BLT.09.067801 - DOI - PMC - PubMed
    1. Anti-tuberculosis drug resistance in the world, Report No. 4: The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance.Geneva: World Health Organization; 2008http://apps.who.int/iris/bitstream/10665/43889/1/WHO_HTM_TB_2008.394_eng...accessed 16 May 2016
    1. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva: World Health Organization; 2010. http://apps.who.int/iris/bitstream/10665/44286/1/9789241599191_eng.pdf?u... accessed 16 May 2016.
    1. Nhung NV, Hoa NB, Sy DN, Hennig CM, Dean AS. The fourth national anti-tuberculosis drug resistance survey in Viet Nam. Int J Tuberc Lung Dis. 2015. June;19(6):670–5. 10.5588/ijtld.14.0785 - DOI - PubMed

Substances

LinkOut - more resources